| Jordan Carly Jane Beck, MS, CCC/SLP | |
|
1354 N 65th St, Wauwatosa, WI 53213-2972 | |
| (414) 208-0753 | |
| Not Available |
| Full Name | Jordan Carly Jane Beck |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1354 N 65th St, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497086243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3132-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Carly Jane Beck, MS, CCC/SLP 1354 N 65th St, Wauwatosa, WI 53213-2972 Ph: (414) 208-0753 | Jordan Carly Jane Beck, MS, CCC/SLP 1354 N 65th St, Wauwatosa, WI 53213-2972 Ph: (414) 208-0753 |
News Archive
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Tackling fuel poverty in the homes of people with sickle cell disease could reduce debilitating attacks and save significant money for the NHS, according to a study by Sheffield Hallam University funded by the Chesshire Lehmann Fund.
Lucideon, the international materials technology company, has released a new video to showcase its services for the healthcare industries, including the medical devices, consumer healthcare and pharmaceutical sectors...
There is now a clear target for the treatment of acute pancreatitis, according to researchers at Lund University in Sweden, who have discovered that a well-known protein plays a central role in the development of the disease. It is likely that the protein is also highly significant for other inflammatory diseases.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.
› Verified 5 days ago
Bethany Ann Collins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10130 W Nash St, Wauwatosa, WI 53222 Phone: 262-337-0565 | |
Rona Alexander, Phd, Ccc-slp, Ltd. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3221 N 104th St, Wauwatosa, WI 53222 Phone: 414-771-8117 Fax: 414-771-7421 | |
Lynn Meehan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10332 W. Woodward Avenue, Wauwatosa, WI 53222 Phone: 414-462-2021 | |
Kristen E Loeper, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 10101 W Wisconsin Ave, Wauwatosa, WI 53226 Phone: 414-259-4549 | |
Julie Anne Koch, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 N 92nd St, Wauwatosa, WI 53226 Phone: 414-259-1414 Fax: 414-259-0575 | |
Lauren Cook Speech & Language Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 N 86th St, Wauwatosa, WI 53226 Phone: 847-322-1126 Fax: 847-322-1126 | |
Tosa Speech Language Pathology Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1354 N 65th St, Wauwatosa, WI 53213 Phone: 414-807-7512 |